Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for ZNF384
Z-value: 2.19
Motif logo
Transcription factors associated with ZNF384
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ZNF384
|
ENSG00000126746.13 | zinc finger protein 384 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZNF384 | hg19_v2_chr12_-_6798410_6798503 | 0.87 | 8.0e-07 | Click! |
Activity profile of ZNF384 motif
Sorted Z-values of ZNF384 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr2_-_85555086 | 4.10 |
ENST00000444342.2
ENST00000409232.3 ENST00000409015.1 |
TGOLN2
|
trans-golgi network protein 2 |
| chr3_-_108308241 | 3.36 |
ENST00000295746.8
|
KIAA1524
|
KIAA1524 |
| chr4_-_122744998 | 2.97 |
ENST00000274026.5
|
CCNA2
|
cyclin A2 |
| chr17_-_38574169 | 2.91 |
ENST00000423485.1
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa |
| chr3_-_185641681 | 2.64 |
ENST00000259043.7
|
TRA2B
|
transformer 2 beta homolog (Drosophila) |
| chr2_-_111435610 | 2.62 |
ENST00000447014.1
ENST00000420328.1 ENST00000535254.1 ENST00000409311.1 ENST00000302759.6 |
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase |
| chr7_-_35013217 | 2.60 |
ENST00000446375.1
|
DPY19L1
|
dpy-19-like 1 (C. elegans) |
| chr4_-_189030422 | 2.52 |
ENST00000536972.1
|
TRIML2
|
tripartite motif family-like 2 |
| chr7_-_108097144 | 2.49 |
ENST00000418239.1
|
NRCAM
|
neuronal cell adhesion molecule |
| chr5_+_118691008 | 2.46 |
ENST00000504642.1
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
| chr4_+_178230985 | 2.32 |
ENST00000264596.3
|
NEIL3
|
nei endonuclease VIII-like 3 (E. coli) |
| chr12_-_76742183 | 2.29 |
ENST00000393262.3
|
BBS10
|
Bardet-Biedl syndrome 10 |
| chr5_+_169010638 | 2.27 |
ENST00000265295.4
ENST00000506574.1 ENST00000515224.1 ENST00000508247.1 ENST00000513941.1 |
SPDL1
|
spindle apparatus coiled-coil protein 1 |
| chr1_+_214776516 | 2.26 |
ENST00000366955.3
|
CENPF
|
centromere protein F, 350/400kDa |
| chr1_-_63988846 | 2.25 |
ENST00000283568.8
ENST00000371092.3 ENST00000271002.10 |
ITGB3BP
|
integrin beta 3 binding protein (beta3-endonexin) |
| chr12_+_69753448 | 2.20 |
ENST00000247843.2
ENST00000548020.1 ENST00000549685.1 ENST00000552955.1 |
YEATS4
|
YEATS domain containing 4 |
| chr11_+_933555 | 2.17 |
ENST00000534485.1
|
AP2A2
|
adaptor-related protein complex 2, alpha 2 subunit |
| chr2_-_44223089 | 2.16 |
ENST00000447246.1
ENST00000409946.1 ENST00000409659.1 |
LRPPRC
|
leucine-rich pentatricopeptide repeat containing |
| chr6_+_142623758 | 2.15 |
ENST00000541199.1
ENST00000435011.2 |
GPR126
|
G protein-coupled receptor 126 |
| chr5_-_156486120 | 2.10 |
ENST00000522693.1
|
HAVCR1
|
hepatitis A virus cellular receptor 1 |
| chr13_-_30160925 | 2.08 |
ENST00000450494.1
|
SLC7A1
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
| chrX_+_69509870 | 2.04 |
ENST00000374388.3
|
KIF4A
|
kinesin family member 4A |
| chr8_-_27695552 | 2.00 |
ENST00000522944.1
ENST00000301905.4 |
PBK
|
PDZ binding kinase |
| chr2_+_29353520 | 1.98 |
ENST00000438819.1
|
CLIP4
|
CAP-GLY domain containing linker protein family, member 4 |
| chr1_-_244006528 | 1.97 |
ENST00000336199.5
ENST00000263826.5 |
AKT3
|
v-akt murine thymoma viral oncogene homolog 3 |
| chr1_+_45205478 | 1.94 |
ENST00000452259.1
ENST00000372224.4 |
KIF2C
|
kinesin family member 2C |
| chr4_+_169842707 | 1.90 |
ENST00000503290.1
|
PALLD
|
palladin, cytoskeletal associated protein |
| chr15_+_89787180 | 1.88 |
ENST00000300027.8
ENST00000310775.7 ENST00000567891.1 ENST00000564920.1 ENST00000565255.1 ENST00000567996.1 ENST00000451393.2 ENST00000563250.1 |
FANCI
|
Fanconi anemia, complementation group I |
| chr5_+_179135246 | 1.87 |
ENST00000508787.1
|
CANX
|
calnexin |
| chr12_+_69202795 | 1.87 |
ENST00000539479.1
ENST00000393415.3 ENST00000523991.1 ENST00000543323.1 ENST00000393416.2 |
MDM2
|
MDM2 oncogene, E3 ubiquitin protein ligase |
| chr5_+_137514403 | 1.85 |
ENST00000513276.1
|
KIF20A
|
kinesin family member 20A |
| chr1_-_220219775 | 1.83 |
ENST00000609181.1
|
EPRS
|
glutamyl-prolyl-tRNA synthetase |
| chr1_+_45212051 | 1.80 |
ENST00000372222.3
|
KIF2C
|
kinesin family member 2C |
| chr6_+_10528560 | 1.79 |
ENST00000379597.3
|
GCNT2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) |
| chr1_+_212475148 | 1.77 |
ENST00000537030.3
|
PPP2R5A
|
protein phosphatase 2, regulatory subunit B', alpha |
| chr1_-_108742957 | 1.76 |
ENST00000565488.1
|
SLC25A24
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 |
| chr17_+_61151306 | 1.74 |
ENST00000580068.1
ENST00000580466.1 |
TANC2
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
| chr19_-_10311868 | 1.74 |
ENST00000588118.1
ENST00000586800.1 |
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1 |
| chr10_+_95256356 | 1.74 |
ENST00000371485.3
|
CEP55
|
centrosomal protein 55kDa |
| chr11_+_101983176 | 1.73 |
ENST00000524575.1
|
YAP1
|
Yes-associated protein 1 |
| chr5_-_130970723 | 1.73 |
ENST00000308008.6
ENST00000296859.6 ENST00000507093.1 ENST00000510071.1 ENST00000509018.1 ENST00000307984.5 |
RAPGEF6
|
Rap guanine nucleotide exchange factor (GEF) 6 |
| chr11_-_28129656 | 1.73 |
ENST00000263181.6
|
KIF18A
|
kinesin family member 18A |
| chr15_+_66797627 | 1.73 |
ENST00000565627.1
ENST00000564179.1 |
ZWILCH
|
zwilch kinetochore protein |
| chr17_-_26926005 | 1.73 |
ENST00000536674.2
|
SPAG5
|
sperm associated antigen 5 |
| chr16_-_66907139 | 1.71 |
ENST00000561579.2
|
NAE1
|
NEDD8 activating enzyme E1 subunit 1 |
| chr12_+_41136144 | 1.71 |
ENST00000548005.1
ENST00000552248.1 |
CNTN1
|
contactin 1 |
| chr11_+_61891445 | 1.70 |
ENST00000394818.3
ENST00000533896.1 ENST00000278849.4 |
INCENP
|
inner centromere protein antigens 135/155kDa |
| chr10_-_7453445 | 1.66 |
ENST00000379713.3
ENST00000397167.1 ENST00000397160.3 |
SFMBT2
|
Scm-like with four mbt domains 2 |
| chr17_-_40086783 | 1.66 |
ENST00000592970.1
|
ACLY
|
ATP citrate lyase |
| chrX_-_108976410 | 1.65 |
ENST00000504980.1
|
ACSL4
|
acyl-CoA synthetase long-chain family member 4 |
| chr8_+_26435915 | 1.65 |
ENST00000523027.1
|
DPYSL2
|
dihydropyrimidinase-like 2 |
| chr3_-_172428842 | 1.62 |
ENST00000424772.1
|
NCEH1
|
neutral cholesterol ester hydrolase 1 |
| chr12_-_106480587 | 1.62 |
ENST00000548902.1
|
NUAK1
|
NUAK family, SNF1-like kinase, 1 |
| chr15_+_29211570 | 1.60 |
ENST00000558804.1
|
APBA2
|
amyloid beta (A4) precursor protein-binding, family A, member 2 |
| chr15_+_66797455 | 1.60 |
ENST00000446801.2
|
ZWILCH
|
zwilch kinetochore protein |
| chr5_-_37371163 | 1.59 |
ENST00000513532.1
|
NUP155
|
nucleoporin 155kDa |
| chr5_+_138611798 | 1.59 |
ENST00000502394.1
|
MATR3
|
matrin 3 |
| chr12_-_102224457 | 1.59 |
ENST00000549165.1
ENST00000549940.1 ENST00000392919.4 |
GNPTAB
|
N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits |
| chr15_+_63050785 | 1.58 |
ENST00000472902.1
|
TLN2
|
talin 2 |
| chr2_-_44588624 | 1.57 |
ENST00000438314.1
ENST00000409936.1 |
PREPL
|
prolyl endopeptidase-like |
| chr15_+_99433570 | 1.57 |
ENST00000558898.1
|
IGF1R
|
insulin-like growth factor 1 receptor |
| chr1_+_45205591 | 1.55 |
ENST00000455186.1
|
KIF2C
|
kinesin family member 2C |
| chr1_+_95582881 | 1.55 |
ENST00000370203.4
ENST00000456991.1 |
TMEM56
|
transmembrane protein 56 |
| chr13_+_114239588 | 1.52 |
ENST00000544902.1
ENST00000408980.2 ENST00000453989.1 |
TFDP1
|
transcription factor Dp-1 |
| chr1_+_215740709 | 1.52 |
ENST00000259154.4
|
KCTD3
|
potassium channel tetramerization domain containing 3 |
| chr6_+_26156551 | 1.51 |
ENST00000304218.3
|
HIST1H1E
|
histone cluster 1, H1e |
| chr12_+_69202975 | 1.51 |
ENST00000544561.1
ENST00000393410.1 ENST00000299252.4 ENST00000360430.2 ENST00000517852.1 ENST00000545204.1 ENST00000393413.3 ENST00000350057.5 ENST00000348801.2 ENST00000478070.1 |
MDM2
|
MDM2 oncogene, E3 ubiquitin protein ligase |
| chrX_+_122993657 | 1.50 |
ENST00000434753.3
ENST00000430625.1 |
XIAP
|
X-linked inhibitor of apoptosis |
| chr8_-_90993869 | 1.50 |
ENST00000517772.1
|
NBN
|
nibrin |
| chr20_+_2083540 | 1.49 |
ENST00000400064.3
|
STK35
|
serine/threonine kinase 35 |
| chr4_-_84205905 | 1.49 |
ENST00000311461.7
ENST00000311469.4 ENST00000439031.2 |
COQ2
|
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
| chr10_-_14614311 | 1.49 |
ENST00000479731.1
ENST00000468492.1 |
FAM107B
|
family with sequence similarity 107, member B |
| chrX_+_69509927 | 1.49 |
ENST00000374403.3
|
KIF4A
|
kinesin family member 4A |
| chr12_+_100594557 | 1.48 |
ENST00000546902.1
ENST00000552376.1 ENST00000551617.1 |
ACTR6
|
ARP6 actin-related protein 6 homolog (yeast) |
| chr2_-_105924778 | 1.48 |
ENST00000258449.1
|
TGFBRAP1
|
transforming growth factor, beta receptor associated protein 1 |
| chr10_+_105036909 | 1.48 |
ENST00000369849.4
|
INA
|
internexin neuronal intermediate filament protein, alpha |
| chr12_-_100486668 | 1.48 |
ENST00000550544.1
ENST00000551980.1 ENST00000548045.1 ENST00000545232.2 ENST00000551973.1 |
UHRF1BP1L
|
UHRF1 binding protein 1-like |
| chr2_-_242211359 | 1.47 |
ENST00000444092.1
|
HDLBP
|
high density lipoprotein binding protein |
| chr5_+_169011033 | 1.46 |
ENST00000513795.1
|
SPDL1
|
spindle apparatus coiled-coil protein 1 |
| chr14_-_51027838 | 1.46 |
ENST00000555216.1
|
MAP4K5
|
mitogen-activated protein kinase kinase kinase kinase 5 |
| chr11_+_19799327 | 1.45 |
ENST00000540292.1
|
NAV2
|
neuron navigator 2 |
| chr17_+_76210267 | 1.45 |
ENST00000301633.4
ENST00000350051.3 ENST00000374948.2 ENST00000590449.1 |
BIRC5
|
baculoviral IAP repeat containing 5 |
| chr15_-_35280426 | 1.45 |
ENST00000559564.1
ENST00000356321.4 |
ZNF770
|
zinc finger protein 770 |
| chr3_-_17783990 | 1.44 |
ENST00000429383.4
ENST00000446863.1 ENST00000414349.1 ENST00000428355.1 ENST00000425944.1 ENST00000445294.1 ENST00000444471.1 ENST00000415814.2 |
TBC1D5
|
TBC1 domain family, member 5 |
| chr7_-_47621229 | 1.44 |
ENST00000434451.1
|
TNS3
|
tensin 3 |
| chr2_+_38893208 | 1.43 |
ENST00000410063.1
|
GALM
|
galactose mutarotase (aldose 1-epimerase) |
| chr1_+_36335351 | 1.43 |
ENST00000373206.1
|
AGO1
|
argonaute RISC catalytic component 1 |
| chr7_-_103848405 | 1.41 |
ENST00000447452.2
ENST00000545943.1 ENST00000297431.4 |
ORC5
|
origin recognition complex, subunit 5 |
| chr3_-_167813132 | 1.40 |
ENST00000309027.4
|
GOLIM4
|
golgi integral membrane protein 4 |
| chr3_+_57261859 | 1.40 |
ENST00000495803.1
ENST00000444459.1 |
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 |
| chr10_-_1094337 | 1.40 |
ENST00000427898.1
|
IDI1
|
isopentenyl-diphosphate delta isomerase 1 |
| chr14_-_45722605 | 1.39 |
ENST00000310806.4
|
MIS18BP1
|
MIS18 binding protein 1 |
| chr6_-_18264406 | 1.39 |
ENST00000515742.1
|
DEK
|
DEK oncogene |
| chr12_-_25150373 | 1.39 |
ENST00000549828.1
|
C12orf77
|
chromosome 12 open reading frame 77 |
| chr1_+_169764163 | 1.38 |
ENST00000413811.2
ENST00000359326.4 ENST00000456684.1 |
C1orf112
|
chromosome 1 open reading frame 112 |
| chr2_+_30670127 | 1.38 |
ENST00000540623.1
ENST00000476038.1 |
LCLAT1
|
lysocardiolipin acyltransferase 1 |
| chr6_+_163837347 | 1.38 |
ENST00000544436.1
|
QKI
|
QKI, KH domain containing, RNA binding |
| chr6_+_126221034 | 1.38 |
ENST00000433571.1
|
NCOA7
|
nuclear receptor coactivator 7 |
| chr12_+_41221794 | 1.38 |
ENST00000547849.1
|
CNTN1
|
contactin 1 |
| chr10_-_58120996 | 1.38 |
ENST00000361148.6
ENST00000395405.1 ENST00000373944.3 |
ZWINT
|
ZW10 interacting kinetochore protein |
| chr13_+_53030107 | 1.37 |
ENST00000490903.1
ENST00000480747.1 |
CKAP2
|
cytoskeleton associated protein 2 |
| chr8_-_55014018 | 1.35 |
ENST00000521352.1
|
LYPLA1
|
lysophospholipase I |
| chr6_-_18249971 | 1.35 |
ENST00000507591.1
|
DEK
|
DEK oncogene |
| chr3_-_167813672 | 1.35 |
ENST00000470487.1
|
GOLIM4
|
golgi integral membrane protein 4 |
| chr15_+_89164560 | 1.35 |
ENST00000379231.3
ENST00000559528.1 |
AEN
|
apoptosis enhancing nuclease |
| chr17_-_20946710 | 1.34 |
ENST00000584538.1
|
USP22
|
ubiquitin specific peptidase 22 |
| chr12_+_34175398 | 1.34 |
ENST00000538927.1
|
ALG10
|
ALG10, alpha-1,2-glucosyltransferase |
| chr3_+_44840679 | 1.34 |
ENST00000425755.1
|
KIF15
|
kinesin family member 15 |
| chr6_-_131277510 | 1.34 |
ENST00000525193.1
ENST00000527659.1 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
| chr16_+_15737124 | 1.34 |
ENST00000396355.1
ENST00000396353.2 |
NDE1
|
nudE neurodevelopment protein 1 |
| chr6_+_63921351 | 1.33 |
ENST00000370659.1
|
FKBP1C
|
FK506 binding protein 1C |
| chr10_+_17270214 | 1.32 |
ENST00000544301.1
|
VIM
|
vimentin |
| chr15_+_80733570 | 1.32 |
ENST00000533983.1
ENST00000527771.1 ENST00000525103.1 |
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2 |
| chrX_+_70503526 | 1.32 |
ENST00000413858.1
ENST00000450092.1 |
NONO
|
non-POU domain containing, octamer-binding |
| chr2_+_196522032 | 1.32 |
ENST00000418005.1
|
SLC39A10
|
solute carrier family 39 (zinc transporter), member 10 |
| chr1_-_94344686 | 1.32 |
ENST00000528680.1
|
DNTTIP2
|
deoxynucleotidyltransferase, terminal, interacting protein 2 |
| chr7_-_107204706 | 1.32 |
ENST00000393603.2
|
COG5
|
component of oligomeric golgi complex 5 |
| chr15_-_35261996 | 1.31 |
ENST00000156471.5
|
AQR
|
aquarius intron-binding spliceosomal factor |
| chr19_-_4717835 | 1.30 |
ENST00000599248.1
|
DPP9
|
dipeptidyl-peptidase 9 |
| chr10_+_96305535 | 1.30 |
ENST00000419900.1
ENST00000348459.5 ENST00000394045.1 ENST00000394044.1 ENST00000394036.1 |
HELLS
|
helicase, lymphoid-specific |
| chr13_+_115079949 | 1.29 |
ENST00000361283.1
|
CHAMP1
|
chromosome alignment maintaining phosphoprotein 1 |
| chr19_-_12551849 | 1.28 |
ENST00000595562.1
ENST00000301547.5 |
CTD-3105H18.16
ZNF443
|
Uncharacterized protein zinc finger protein 443 |
| chr6_-_42185583 | 1.28 |
ENST00000053468.3
|
MRPS10
|
mitochondrial ribosomal protein S10 |
| chr17_-_76220740 | 1.27 |
ENST00000600484.1
|
AC087645.1
|
Uncharacterized protein |
| chr5_+_118690466 | 1.27 |
ENST00000503646.1
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
| chr14_-_45722360 | 1.27 |
ENST00000451174.1
|
MIS18BP1
|
MIS18 binding protein 1 |
| chr8_-_54934708 | 1.25 |
ENST00000520534.1
ENST00000518784.1 ENST00000522635.1 |
TCEA1
|
transcription elongation factor A (SII), 1 |
| chr1_-_68962782 | 1.24 |
ENST00000456315.2
|
DEPDC1
|
DEP domain containing 1 |
| chr9_+_67977438 | 1.23 |
ENST00000456982.1
|
RP11-195B21.3
|
Protein LOC644249 |
| chr10_-_70231639 | 1.22 |
ENST00000551118.2
ENST00000358410.3 ENST00000399180.2 ENST00000399179.2 |
DNA2
|
DNA replication helicase/nuclease 2 |
| chr4_+_123747979 | 1.22 |
ENST00000608478.1
|
FGF2
|
fibroblast growth factor 2 (basic) |
| chr1_+_203765437 | 1.22 |
ENST00000550078.1
|
ZBED6
|
zinc finger, BED-type containing 6 |
| chr2_+_172778952 | 1.22 |
ENST00000392584.1
ENST00000264108.4 |
HAT1
|
histone acetyltransferase 1 |
| chr14_+_31028348 | 1.20 |
ENST00000550944.1
ENST00000438909.2 ENST00000553504.1 |
G2E3
|
G2/M-phase specific E3 ubiquitin protein ligase |
| chr10_+_5135981 | 1.20 |
ENST00000380554.3
|
AKR1C3
|
aldo-keto reductase family 1, member C3 |
| chr1_+_45205498 | 1.20 |
ENST00000372218.4
|
KIF2C
|
kinesin family member 2C |
| chr16_-_84150392 | 1.20 |
ENST00000570012.1
|
MBTPS1
|
membrane-bound transcription factor peptidase, site 1 |
| chr2_+_191792376 | 1.19 |
ENST00000409428.1
ENST00000409215.1 |
GLS
|
glutaminase |
| chr11_-_108369101 | 1.19 |
ENST00000323468.5
|
KDELC2
|
KDEL (Lys-Asp-Glu-Leu) containing 2 |
| chr14_+_93673574 | 1.19 |
ENST00000554232.1
ENST00000556871.1 ENST00000555113.1 |
UBR7
|
ubiquitin protein ligase E3 component n-recognin 7 (putative) |
| chr7_-_75241096 | 1.19 |
ENST00000420909.1
|
HIP1
|
huntingtin interacting protein 1 |
| chr12_+_57522692 | 1.19 |
ENST00000554174.1
|
LRP1
|
low density lipoprotein receptor-related protein 1 |
| chr2_+_11295498 | 1.18 |
ENST00000295083.3
ENST00000441908.2 |
PQLC3
|
PQ loop repeat containing 3 |
| chr2_-_112614424 | 1.18 |
ENST00000427997.1
|
ANAPC1
|
anaphase promoting complex subunit 1 |
| chr15_+_40886439 | 1.18 |
ENST00000532056.1
ENST00000399668.2 |
CASC5
|
cancer susceptibility candidate 5 |
| chr20_+_21284416 | 1.17 |
ENST00000539513.1
|
XRN2
|
5'-3' exoribonuclease 2 |
| chr10_+_126490354 | 1.17 |
ENST00000298492.5
|
FAM175B
|
family with sequence similarity 175, member B |
| chr4_+_123747834 | 1.17 |
ENST00000264498.3
|
FGF2
|
fibroblast growth factor 2 (basic) |
| chr2_+_109403193 | 1.16 |
ENST00000412964.2
ENST00000295124.4 |
CCDC138
|
coiled-coil domain containing 138 |
| chr11_+_74303612 | 1.16 |
ENST00000527458.1
ENST00000532497.1 ENST00000530511.1 |
POLD3
|
polymerase (DNA-directed), delta 3, accessory subunit |
| chr17_+_44701402 | 1.16 |
ENST00000575068.1
|
NSF
|
N-ethylmaleimide-sensitive factor |
| chr7_+_87505544 | 1.15 |
ENST00000265728.1
|
DBF4
|
DBF4 homolog (S. cerevisiae) |
| chr13_+_32889605 | 1.15 |
ENST00000380152.3
ENST00000544455.1 ENST00000530893.2 |
BRCA2
|
breast cancer 2, early onset |
| chr1_+_77748756 | 1.15 |
ENST00000478407.1
|
AK5
|
adenylate kinase 5 |
| chr1_+_64014588 | 1.15 |
ENST00000371086.2
ENST00000340052.3 |
DLEU2L
|
deleted in lymphocytic leukemia 2-like |
| chr6_+_89855765 | 1.15 |
ENST00000275072.4
|
PM20D2
|
peptidase M20 domain containing 2 |
| chr8_+_27631903 | 1.15 |
ENST00000305188.8
|
ESCO2
|
establishment of sister chromatid cohesion N-acetyltransferase 2 |
| chr2_-_61765732 | 1.15 |
ENST00000443240.1
ENST00000436018.1 |
XPO1
|
exportin 1 (CRM1 homolog, yeast) |
| chr18_-_3013307 | 1.14 |
ENST00000584294.1
|
LPIN2
|
lipin 2 |
| chr6_+_151561506 | 1.14 |
ENST00000253332.1
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr12_-_90024360 | 1.14 |
ENST00000393164.2
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1 |
| chr9_+_108463234 | 1.13 |
ENST00000374688.1
|
TMEM38B
|
transmembrane protein 38B |
| chr16_+_53483983 | 1.13 |
ENST00000544545.1
|
RBL2
|
retinoblastoma-like 2 (p130) |
| chr1_+_45212074 | 1.13 |
ENST00000372217.1
|
KIF2C
|
kinesin family member 2C |
| chrX_-_119709637 | 1.12 |
ENST00000404115.3
|
CUL4B
|
cullin 4B |
| chr17_+_38444115 | 1.12 |
ENST00000580824.1
ENST00000577249.1 |
CDC6
|
cell division cycle 6 |
| chr12_-_47473557 | 1.12 |
ENST00000321382.3
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr6_-_41888843 | 1.11 |
ENST00000434077.1
ENST00000409312.1 |
MED20
|
mediator complex subunit 20 |
| chr12_+_6603253 | 1.11 |
ENST00000382457.4
ENST00000545962.1 |
NCAPD2
|
non-SMC condensin I complex, subunit D2 |
| chr17_+_46985823 | 1.11 |
ENST00000508468.2
|
UBE2Z
|
ubiquitin-conjugating enzyme E2Z |
| chr4_+_103790462 | 1.11 |
ENST00000503643.1
|
CISD2
|
CDGSH iron sulfur domain 2 |
| chr15_+_78441663 | 1.11 |
ENST00000299518.2
ENST00000558554.1 ENST00000557826.1 ENST00000561279.1 ENST00000559186.1 ENST00000560770.1 ENST00000559881.1 ENST00000559205.1 ENST00000441490.2 |
IDH3A
|
isocitrate dehydrogenase 3 (NAD+) alpha |
| chr16_+_75182376 | 1.11 |
ENST00000570010.1
ENST00000568079.1 ENST00000464850.1 ENST00000332307.4 ENST00000393430.2 |
ZFP1
|
ZFP1 zinc finger protein |
| chrX_-_84634708 | 1.11 |
ENST00000373145.3
|
POF1B
|
premature ovarian failure, 1B |
| chr9_+_106856831 | 1.11 |
ENST00000303219.8
ENST00000374787.3 |
SMC2
|
structural maintenance of chromosomes 2 |
| chr15_-_101137121 | 1.10 |
ENST00000560934.1
|
LINS
|
lines homolog (Drosophila) |
| chr2_+_183989157 | 1.10 |
ENST00000541912.1
|
NUP35
|
nucleoporin 35kDa |
| chr12_-_75905374 | 1.10 |
ENST00000438169.2
ENST00000229214.4 |
KRR1
|
KRR1, small subunit (SSU) processome component, homolog (yeast) |
| chr14_-_64108125 | 1.10 |
ENST00000267522.3
|
WDR89
|
WD repeat domain 89 |
| chr12_+_100660909 | 1.09 |
ENST00000549687.1
|
SCYL2
|
SCY1-like 2 (S. cerevisiae) |
| chr1_-_68962805 | 1.09 |
ENST00000370966.5
|
DEPDC1
|
DEP domain containing 1 |
| chr5_+_172261356 | 1.09 |
ENST00000523291.1
|
ERGIC1
|
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
| chr12_-_123717643 | 1.08 |
ENST00000541437.1
ENST00000606320.1 |
MPHOSPH9
|
M-phase phosphoprotein 9 |
| chr19_+_7599792 | 1.08 |
ENST00000600942.1
ENST00000593924.1 |
PNPLA6
|
patatin-like phospholipase domain containing 6 |
| chr16_-_71323617 | 1.08 |
ENST00000563876.1
|
CMTR2
|
cap methyltransferase 2 |
| chr3_-_179169330 | 1.08 |
ENST00000232564.3
|
GNB4
|
guanine nucleotide binding protein (G protein), beta polypeptide 4 |
| chr18_-_2982869 | 1.07 |
ENST00000584915.1
|
LPIN2
|
lipin 2 |
| chr10_+_94352956 | 1.07 |
ENST00000260731.3
|
KIF11
|
kinesin family member 11 |
| chrX_+_64808248 | 1.07 |
ENST00000609672.1
|
MSN
|
moesin |
| chr10_+_5090940 | 1.07 |
ENST00000602997.1
|
AKR1C3
|
aldo-keto reductase family 1, member C3 |
| chr7_-_107968921 | 1.07 |
ENST00000442580.1
|
NRCAM
|
neuronal cell adhesion molecule |
| chr6_-_166401402 | 1.07 |
ENST00000581850.1
ENST00000444465.1 |
LINC00473
|
long intergenic non-protein coding RNA 473 |
| chr16_-_2379688 | 1.07 |
ENST00000567910.1
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3 |
| chr2_-_169769787 | 1.06 |
ENST00000451987.1
|
SPC25
|
SPC25, NDC80 kinetochore complex component |
| chr1_-_115301235 | 1.05 |
ENST00000525878.1
|
CSDE1
|
cold shock domain containing E1, RNA-binding |
| chr10_+_70715884 | 1.05 |
ENST00000354185.4
|
DDX21
|
DEAD (Asp-Glu-Ala-Asp) box helicase 21 |
| chrX_-_135056106 | 1.05 |
ENST00000433339.2
|
MMGT1
|
membrane magnesium transporter 1 |
| chr2_-_170430277 | 1.05 |
ENST00000438035.1
ENST00000453929.2 |
FASTKD1
|
FAST kinase domains 1 |
| chr9_+_132565454 | 1.05 |
ENST00000427860.1
|
TOR1B
|
torsin family 1, member B (torsin B) |
| chr17_+_3627185 | 1.04 |
ENST00000325418.4
|
GSG2
|
germ cell associated 2 (haspin) |
Network of associatons between targets according to the STRING database.
First level regulatory network of ZNF384
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 3.4 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 1.0 | 3.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 0.8 | 2.5 | GO:1990641 | response to iron ion starvation(GO:1990641) |
| 0.8 | 2.4 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 0.8 | 3.9 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.8 | 2.3 | GO:2000224 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.7 | 2.2 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.7 | 2.1 | GO:0006433 | glutamyl-tRNA aminoacylation(GO:0006424) prolyl-tRNA aminoacylation(GO:0006433) |
| 0.7 | 2.6 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.6 | 7.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.6 | 1.8 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.6 | 2.3 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.6 | 1.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.5 | 1.6 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.5 | 0.5 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.5 | 2.0 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.5 | 0.5 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.5 | 2.4 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.5 | 1.9 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.5 | 2.7 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.4 | 0.4 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.4 | 1.3 | GO:2001112 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
| 0.4 | 0.4 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.4 | 1.7 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.4 | 1.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.4 | 3.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.4 | 2.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.4 | 1.6 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.4 | 1.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.4 | 1.2 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.4 | 1.2 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
| 0.4 | 1.1 | GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.4 | 6.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.4 | 1.5 | GO:0051598 | meiotic recombination checkpoint(GO:0051598) |
| 0.4 | 6.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.4 | 2.5 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.4 | 1.1 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.4 | 2.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.3 | 1.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.3 | 2.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.3 | 1.4 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.3 | 1.4 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.3 | 3.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.3 | 3.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.3 | 2.0 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.3 | 3.0 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.3 | 0.3 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.3 | 1.0 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.3 | 1.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.3 | 0.9 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.3 | 1.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.3 | 1.9 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.3 | 0.3 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.3 | 1.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 | 0.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.3 | 0.9 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.3 | 0.9 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.3 | 0.9 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.3 | 1.2 | GO:0060032 | notochord regression(GO:0060032) |
| 0.3 | 2.4 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.3 | 0.9 | GO:0042245 | RNA repair(GO:0042245) |
| 0.3 | 0.9 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.3 | 2.3 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.3 | 1.5 | GO:1902904 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.3 | 1.2 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.3 | 1.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.3 | 2.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.3 | 0.9 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.3 | 3.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.3 | 1.9 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.3 | 0.8 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.3 | 0.8 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.3 | 0.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.3 | 0.5 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.3 | 2.9 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.3 | 2.1 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
| 0.3 | 1.0 | GO:0051808 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.3 | 1.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 | 0.7 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.2 | 2.6 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.2 | 1.0 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.2 | 3.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 | 0.7 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.2 | 6.1 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.2 | 1.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.2 | 2.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.2 | 1.2 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.2 | 2.1 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.2 | 1.1 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.2 | 0.7 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.2 | 1.1 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 0.2 | 3.8 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.2 | 1.6 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.2 | 0.9 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.2 | 7.9 | GO:0061641 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.2 | 1.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.2 | 2.2 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 | 0.9 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 | 0.9 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.2 | 1.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.2 | 2.6 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.2 | 0.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.2 | 2.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 | 1.0 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.2 | 1.7 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.2 | 0.6 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 0.2 | 0.8 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.2 | 0.4 | GO:0016575 | histone deacetylation(GO:0016575) regulation of histone deacetylation(GO:0031063) positive regulation of chromatin modification(GO:1903310) |
| 0.2 | 0.8 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 | 4.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.2 | 1.2 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.2 | 0.4 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.2 | 0.8 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.2 | 1.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.2 | 1.6 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 0.2 | 0.4 | GO:0006203 | dGTP catabolic process(GO:0006203) |
| 0.2 | 0.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 0.2 | 1.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.2 | 2.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.2 | 0.8 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.2 | 0.6 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.2 | 3.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.2 | 1.5 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 0.2 | 0.4 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
| 0.2 | 0.6 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.2 | 1.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.2 | 3.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.2 | 5.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.2 | 1.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.2 | 1.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.2 | 0.5 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.2 | 0.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.2 | 1.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.2 | 0.7 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.2 | 1.4 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 | 1.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.2 | 0.2 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.2 | 1.4 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.2 | 0.7 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.2 | 1.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.2 | 0.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.2 | 1.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 | 1.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 | 1.3 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.2 | 0.5 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.2 | 2.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.2 | 0.5 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.2 | 0.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.2 | 1.0 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.2 | 2.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.2 | 1.5 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 | 0.5 | GO:0003163 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
| 0.2 | 0.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 | 0.7 | GO:0042779 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
| 0.2 | 0.6 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.2 | 1.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 | 0.8 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 0.2 | 5.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.2 | 3.2 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.2 | 0.6 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.2 | 0.5 | GO:1903527 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
| 0.2 | 1.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.2 | 4.3 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.2 | 0.6 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 | 0.6 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.2 | 1.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.2 | 1.7 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.2 | 0.5 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.2 | 1.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 | 0.5 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.2 | 0.2 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.2 | 1.7 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.2 | 0.6 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
| 0.1 | 1.0 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.1 | 0.3 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.1 | 1.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 | 2.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 | 0.7 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.1 | 1.9 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.1 | 1.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 3.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 | 1.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 | 0.6 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 | 0.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 | 0.7 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 | 1.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 | 2.4 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 | 0.6 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.1 | 0.6 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
| 0.1 | 1.1 | GO:1902996 | regulation of neurofibrillary tangle assembly(GO:1902996) |
| 0.1 | 1.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 0.4 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.1 | 0.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.1 | 0.3 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 | 0.3 | GO:0007135 | meiosis II(GO:0007135) |
| 0.1 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 | 0.7 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.1 | 0.5 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 | 0.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.1 | 0.3 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
| 0.1 | 3.0 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 | 3.2 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 | 1.0 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 1.0 | GO:0050893 | sensory processing(GO:0050893) |
| 0.1 | 1.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.1 | 18.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 0.1 | 0.6 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.1 | 1.1 | GO:1990034 | cellular response to corticosterone stimulus(GO:0071386) calcium ion export from cell(GO:1990034) |
| 0.1 | 0.9 | GO:0002353 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.1 | 0.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 | 2.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.1 | 0.5 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.1 | 1.0 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.1 | 3.5 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 0.9 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 0.7 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.1 | 0.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.1 | 0.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.1 | 2.4 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.1 | 1.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 | 0.4 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.1 | 1.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.1 | 0.6 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 1.9 | GO:0015866 | ADP transport(GO:0015866) |
| 0.1 | 0.2 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.1 | 0.7 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.1 | 2.0 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 | 1.4 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.1 | 0.2 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 0.1 | 1.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 2.7 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.1 | 0.7 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.1 | 0.5 | GO:1901804 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
| 0.1 | 1.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 0.3 | GO:0060621 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
| 0.1 | 0.2 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 0.1 | 2.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.1 | 0.6 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.1 | 0.8 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.1 | 3.4 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.1 | 1.2 | GO:0042262 | DNA protection(GO:0042262) |
| 0.1 | 0.9 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.1 | 1.1 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.1 | 1.0 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.1 | 1.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
| 0.1 | 0.2 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.1 | 0.2 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 0.1 | 0.2 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
| 0.1 | 0.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.1 | 0.3 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.1 | 0.4 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.1 | 0.3 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
| 0.1 | 0.8 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.1 | 0.4 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 | 0.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 2.8 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.1 | 1.4 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 0.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 0.1 | 0.5 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.1 | 1.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 0.4 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.1 | 0.6 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.1 | 0.3 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.1 | 0.2 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.1 | 2.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 0.3 | GO:0050904 | diapedesis(GO:0050904) |
| 0.1 | 0.3 | GO:2000340 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
| 0.1 | 0.3 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 | 0.6 | GO:0030047 | actin modification(GO:0030047) |
| 0.1 | 5.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 | 0.2 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.1 | 0.4 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.1 | 0.7 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.1 | 0.6 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.1 | 0.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 | 0.5 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
| 0.1 | 0.8 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 1.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.1 | 0.7 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.1 | 0.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
| 0.1 | 0.3 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 | 0.5 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 | 0.7 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.1 | 0.8 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.1 | 0.6 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.1 | 0.7 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.1 | 0.4 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.1 | 1.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 | 1.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 | 0.4 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.1 | 0.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 | 2.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 1.8 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 | 0.8 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.1 | 1.7 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.1 | 0.3 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
| 0.1 | 1.0 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.1 | 1.8 | GO:0006999 | nuclear pore organization(GO:0006999) |
| 0.1 | 0.5 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.1 | 0.4 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 | 0.8 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 0.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 | 2.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.1 | 0.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.1 | 2.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.1 | 1.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.1 | 0.4 | GO:0033504 | floor plate development(GO:0033504) |
| 0.1 | 0.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.1 | 0.5 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.1 | 0.9 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.1 | 0.1 | GO:0046495 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.1 | 0.8 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.1 | 0.3 | GO:0032328 | alanine transport(GO:0032328) |
| 0.1 | 0.7 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.1 | 0.2 | GO:0003285 | septum secundum development(GO:0003285) |
| 0.1 | 0.6 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.1 | 1.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.3 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.1 | 0.4 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.1 | 0.6 | GO:0060613 | fat pad development(GO:0060613) |
| 0.1 | 1.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 | 0.4 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 0.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 | 1.1 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.1 | 0.8 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.1 | 0.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.1 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.1 | 0.6 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.1 | 1.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 0.4 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.1 | 0.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.1 | 0.3 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.1 | 1.3 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 0.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 | 0.3 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.1 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 | 0.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 1.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.1 | 0.3 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.1 | 0.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 | 1.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.1 | 3.6 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 | 1.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 | 0.9 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 0.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 | 0.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.1 | 1.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 2.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 | 0.8 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.1 | 0.4 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 | 1.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.1 | 0.5 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.1 | 0.9 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 0.8 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 | 1.1 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.1 | 0.2 | GO:0045829 | negative regulation of isotype switching(GO:0045829) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.1 | 1.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 | 0.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.1 | 0.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 | 0.3 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.1 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 | 0.7 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.1 | 1.3 | GO:0006312 | mitotic recombination(GO:0006312) |
| 0.1 | 4.5 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.1 | 0.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 0.8 | GO:0000732 | strand displacement(GO:0000732) |
| 0.1 | 0.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 | 0.4 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.1 | 1.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 | 0.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 1.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.1 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 | 0.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 0.1 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.1 | 0.7 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.1 | 0.2 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.1 | 0.1 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 | 0.5 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.1 | 0.6 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.1 | 0.8 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.1 | 0.7 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 0.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.1 | 0.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.1 | 1.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.1 | 0.5 | GO:0031054 | pre-miRNA processing(GO:0031054) |
| 0.1 | 0.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.1 | 0.5 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.1 | 0.5 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.1 | 0.3 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.1 | 0.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.1 | 0.1 | GO:0010266 | response to vitamin B1(GO:0010266) |
| 0.1 | 0.4 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 | 0.3 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 | 3.0 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 | 0.3 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.1 | 0.7 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.1 | 0.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.1 | 0.5 | GO:0060021 | palate development(GO:0060021) |
| 0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 0.9 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.1 | 0.3 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.1 | 0.5 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.1 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 | 1.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 | 0.9 | GO:0006071 | glycerol metabolic process(GO:0006071) |
| 0.1 | 5.7 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.1 | 0.2 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 | 0.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.1 | 1.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 0.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 0.5 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.1 | 1.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 | 0.4 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.1 | 0.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.1 | 0.5 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.1 | 0.4 | GO:0016246 | RNA interference(GO:0016246) |
| 0.1 | 0.9 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 0.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.1 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.1 | 0.4 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.1 | 0.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.1 | 0.5 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.1 | 0.8 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.1 | 0.2 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.1 | 0.2 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.1 | 0.6 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.1 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 | 0.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.1 | 2.6 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.1 | 0.5 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.1 | 0.7 | GO:0046479 | ganglioside catabolic process(GO:0006689) glycosphingolipid catabolic process(GO:0046479) |
| 0.1 | 2.2 | GO:0051168 | nuclear export(GO:0051168) |
| 0.1 | 0.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 0.1 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.1 | 0.8 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.1 | 0.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.1 | 0.2 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
| 0.1 | 0.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
| 0.1 | 2.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 | 1.9 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 0.1 | 0.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 | 0.4 | GO:1902731 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.1 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 | 0.8 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 0.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.1 | 0.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 | 0.4 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 0.7 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.1 | 0.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 | 1.6 | GO:0034204 | lipid translocation(GO:0034204) |
| 0.1 | 0.2 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.1 | 0.3 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.1 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 0.1 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.0 | 1.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.0 | 1.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 | 0.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.0 | 0.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.0 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 | 0.2 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.0 | 0.9 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.0 | 0.2 | GO:0010157 | response to chlorate(GO:0010157) |
| 0.0 | 1.0 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 | 2.0 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.0 | 0.2 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.0 | 0.6 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 | 0.5 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.0 | 0.3 | GO:0006574 | valine metabolic process(GO:0006573) valine catabolic process(GO:0006574) |
| 0.0 | 0.2 | GO:0050758 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
| 0.0 | 0.3 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.0 | 1.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 0.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.0 | 0.3 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.0 | 0.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
| 0.0 | 1.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 | 0.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
| 0.0 | 0.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 | 0.3 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
| 0.0 | 2.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.2 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.0 | 0.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.0 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.0 | 0.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 | 0.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.0 | 0.2 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 0.0 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 | 0.3 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.0 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.0 | 0.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 | 0.7 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.0 | 0.2 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.0 | 0.2 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.0 | 1.7 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.0 | 0.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 | 0.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.0 | 0.3 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.0 | 0.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.0 | 0.4 | GO:0097435 | fibril organization(GO:0097435) |
| 0.0 | 1.4 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.0 | 0.8 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.0 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 | 0.4 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.0 | 2.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 | 0.1 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.0 | 0.4 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.0 | 0.3 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.0 | 0.2 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.0 | 0.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 | 0.6 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 | 0.6 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.0 | 0.8 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.0 | 0.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.0 | 0.7 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.0 | 0.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.0 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.0 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.0 | 2.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.0 | 0.6 | GO:0014870 | response to muscle inactivity(GO:0014870) |
| 0.0 | 0.4 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 0.0 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.0 | 0.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 | 0.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.0 | 0.5 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
| 0.0 | 0.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.0 | 0.1 | GO:0045324 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) late endosome to vacuole transport(GO:0045324) |
| 0.0 | 0.5 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.0 | 0.1 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.0 | 1.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 | 0.7 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.0 | 0.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 0.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.0 | 1.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.0 | 0.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 | 0.4 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.0 | 0.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.0 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
| 0.0 | 0.1 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.0 | 0.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 | 1.1 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.0 | 0.5 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.0 | 0.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.0 | 0.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 1.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.0 | 0.3 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.0 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.0 | 2.0 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 | 1.4 | GO:0030325 | adrenal gland development(GO:0030325) |
| 0.0 | 0.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.0 | 2.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.5 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
| 0.0 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 | 0.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.0 | 0.1 | GO:1904586 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.0 | 0.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.0 | 0.1 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.0 | 0.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.0 | 0.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 | 1.9 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.0 | 0.1 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
| 0.0 | 0.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.0 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.0 | 0.4 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.0 | 0.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.0 | 0.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.0 | 0.4 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 0.0 | 0.4 | GO:0072189 | ureter development(GO:0072189) |
| 0.0 | 0.6 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.0 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
| 0.0 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.0 | 0.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 0.0 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.0 | 0.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.0 | 0.1 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 0.0 | 0.2 | GO:1901523 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) long-chain fatty acid catabolic process(GO:0042758) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.0 | 0.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 | 1.6 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
| 0.0 | 0.2 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
| 0.0 | 0.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.0 | 0.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.0 | 1.1 | GO:0010259 | multicellular organism aging(GO:0010259) |
| 0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
| 0.0 | 0.1 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
| 0.0 | 0.1 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.0 | 0.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.0 | 0.0 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.0 | 0.1 | GO:1901741 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
| 0.0 | 0.7 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.0 | 1.9 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
| 0.0 | 0.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 0.0 | 0.1 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.0 | 0.1 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.0 | 0.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.0 | 0.6 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 | 0.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.0 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.0 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.3 | GO:0097502 | mannosylation(GO:0097502) |
| 0.0 | 0.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.0 | 0.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.0 | 0.1 | GO:1901383 | negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
| 0.0 | 0.1 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.0 | 0.2 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
| 0.0 | 0.7 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.0 | 0.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 | 0.2 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.0 | 0.6 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.0 | 0.1 | GO:0035284 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
| 0.0 | 1.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.0 | 2.8 | GO:0007051 | spindle organization(GO:0007051) |
| 0.0 | 0.1 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.0 | 0.2 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
| 0.0 | 2.2 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.0 | 0.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.0 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.0 | 0.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.0 | 0.1 | GO:0061743 | motor learning(GO:0061743) |
| 0.0 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.0 | 0.2 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 | 0.0 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
| 0.0 | 0.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.0 | 0.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.0 | 1.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.0 | 0.1 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.0 | 0.4 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.0 | 0.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.0 | 0.2 | GO:0032446 | protein modification by small protein conjugation(GO:0032446) |
| 0.0 | 0.1 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
| 0.0 | 0.8 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
| 0.0 | 0.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 0.1 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.0 | 0.3 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.0 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 | 0.6 | GO:0051298 | centrosome duplication(GO:0051298) |
| 0.0 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
| 0.0 | 0.2 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
| 0.0 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 | 1.2 | GO:0051170 | nuclear import(GO:0051170) |
| 0.0 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.0 | 0.8 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 | 0.1 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.0 | 0.8 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
| 0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.0 | 0.2 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.0 | 0.2 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
| 0.0 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.0 | 0.7 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
| 0.0 | 0.2 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 | 0.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 | 1.0 | GO:0006446 | regulation of translational initiation(GO:0006446) |
| 0.0 | 0.0 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.0 | 0.2 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.0 | 0.6 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 | 0.7 | GO:0061512 | protein localization to cilium(GO:0061512) |
| 0.0 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.0 | 1.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.0 | 0.4 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.0 | 0.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.0 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.0 | 0.1 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 | 0.4 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 | 0.4 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.0 | 0.7 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
| 0.0 | 0.3 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
| 0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.0 | 0.8 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.0 | 0.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
| 0.0 | 0.1 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 0.0 | 0.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.0 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.0 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 0.0 | 0.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 | 0.1 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.0 | 0.5 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.0 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.0 | 0.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 | 0.1 | GO:1990592 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 | 0.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.0 | 0.2 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.0 | 0.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.0 | 0.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 0.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.0 | 0.6 | GO:0006739 | NADP metabolic process(GO:0006739) |
| 0.0 | 0.2 | GO:0043470 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
| 0.0 | 0.2 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
| 0.0 | 0.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.0 | 0.1 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.0 | 0.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.0 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.0 | 1.5 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
| 0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.0 | 0.0 | GO:0072757 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.0 | 0.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.0 | 2.8 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.0 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 0.4 | GO:0097009 | energy homeostasis(GO:0097009) |
| 0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 | 0.1 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.0 | 0.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.0 | 2.1 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 | 0.1 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
| 0.0 | 0.1 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.0 | 0.0 | GO:1900920 | regulation of amino acid import(GO:0010958) regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) regulation of calcium:sodium antiporter activity(GO:1903279) negative regulation of calcium:sodium antiporter activity(GO:1903280) |
| 0.0 | 0.0 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.0 | 0.1 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
| 0.0 | 0.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.0 | 0.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.0 | 0.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.0 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
| 0.0 | 0.7 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.0 | 0.8 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
| 0.0 | 0.5 | GO:0043967 | histone H4 acetylation(GO:0043967) |
| 0.0 | 0.3 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.0 | 0.4 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.0 | 0.1 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.0 | 0.1 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
| 0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.0 | 0.4 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 | 0.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.0 | 0.3 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.0 | 0.0 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.0 | 0.0 | GO:0061485 | memory T cell proliferation(GO:0061485) |
| 0.0 | 0.1 | GO:0015879 | carnitine transport(GO:0015879) |
| 0.0 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 | 0.6 | GO:0034763 | negative regulation of transmembrane transport(GO:0034763) |
| 0.0 | 0.2 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.0 | 0.1 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.0 | 0.3 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.0 | 0.0 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.0 | 0.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.0 | 0.2 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
| 0.0 | 0.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.0 | 0.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 | 0.2 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.0 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 3.4 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
| 1.1 | 3.4 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.9 | 3.7 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.6 | 1.7 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.5 | 1.9 | GO:0000811 | GINS complex(GO:0000811) |
| 0.5 | 1.4 | GO:0070993 | translation preinitiation complex(GO:0070993) |
| 0.5 | 1.4 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.5 | 8.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.4 | 2.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.4 | 1.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.4 | 1.1 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.4 | 0.4 | GO:0005712 | chiasma(GO:0005712) |
| 0.3 | 1.7 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.3 | 1.3 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.3 | 3.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.3 | 0.6 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.3 | 2.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.3 | 2.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.3 | 0.6 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.3 | 2.1 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.3 | 4.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.3 | 1.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.3 | 2.7 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.3 | 1.1 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.3 | 2.1 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.3 | 0.8 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.3 | 1.0 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.3 | 0.8 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.3 | 0.8 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.3 | 0.8 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.3 | 0.8 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.3 | 2.0 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.2 | 3.2 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.2 | 0.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.2 | 0.7 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 0.2 | 1.0 | GO:0070985 | TFIIK complex(GO:0070985) |
| 0.2 | 4.7 | GO:0008091 | spectrin(GO:0008091) |
| 0.2 | 0.7 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.2 | 0.7 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.2 | 6.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.2 | 1.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.2 | 21.4 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.2 | 1.7 | GO:1990357 | terminal web(GO:1990357) |
| 0.2 | 1.5 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.2 | 0.8 | GO:0031523 | Myb complex(GO:0031523) |
| 0.2 | 1.4 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.2 | 7.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.2 | 1.2 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.2 | 0.8 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.2 | 1.0 | GO:0071547 | piP-body(GO:0071547) |
| 0.2 | 0.5 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.2 | 0.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.2 | 3.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.2 | 1.4 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.2 | 2.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.2 | 1.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.2 | 1.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.2 | 2.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.2 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.2 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.2 | 0.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.2 | 0.5 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.2 | 1.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 0.6 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.2 | 1.1 | GO:0000796 | condensin complex(GO:0000796) |
| 0.2 | 0.5 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 0.2 | 0.3 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.2 | 0.3 | GO:1990234 | transferase complex(GO:1990234) |
| 0.2 | 4.5 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 2.1 | GO:0034464 | BBSome(GO:0034464) |
| 0.1 | 0.7 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 5.6 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 6.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 0.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.1 | 1.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 0.8 | GO:0001740 | Barr body(GO:0001740) |
| 0.1 | 1.4 | GO:0033503 | HULC complex(GO:0033503) |
| 0.1 | 1.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.1 | 1.5 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.1 | 0.8 | GO:0045179 | apical cortex(GO:0045179) |
| 0.1 | 0.4 | GO:0030684 | preribosome(GO:0030684) |
| 0.1 | 1.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.1 | 0.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 1.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 1.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 2.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 1.0 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.1 | 1.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.1 | 2.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 0.6 | GO:0071942 | XPC complex(GO:0071942) |
| 0.1 | 0.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 0.6 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 5.3 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.1 | 1.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.1 | 0.9 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.1 | 1.3 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 0.3 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.1 | 0.8 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.1 | 1.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.1 | 1.0 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.1 | 1.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.1 | 1.8 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.1 | 2.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 2.0 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 0.4 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 0.8 | GO:0071664 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
| 0.1 | 0.5 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.1 | 2.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 0.8 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 1.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.1 | 0.6 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.1 | 0.6 | GO:0031090 | organelle membrane(GO:0031090) |
| 0.1 | 2.0 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 1.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 9.5 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.1 | 1.2 | GO:0016235 | aggresome(GO:0016235) |
| 0.1 | 1.0 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.1 | 1.9 | GO:0090543 | Flemming body(GO:0090543) |
| 0.1 | 0.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.1 | 1.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.1 | 3.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.1 | 0.9 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.1 | 0.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.1 | 1.7 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 0.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.1 | 1.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.1 | 3.9 | GO:0005657 | replication fork(GO:0005657) |
| 0.1 | 0.5 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.1 | 4.0 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.1 | 1.2 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 8.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.1 | 0.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.1 | 1.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.1 | 0.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.1 | 0.4 | GO:1990752 | microtubule plus-end(GO:0035371) microtubule end(GO:1990752) |
| 0.1 | 2.6 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.2 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.1 | 0.3 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.1 | 0.5 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.1 | 0.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.1 | 4.4 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 1.1 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 1.3 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 0.1 | 0.3 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
| 0.1 | 0.6 | GO:0031415 | NatA complex(GO:0031415) |
| 0.1 | 0.3 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.1 | 0.6 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 0.1 | 1.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.1 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
| 0.1 | 0.2 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.1 | 0.4 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 0.1 | 0.3 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.1 | 0.7 | GO:0051286 | cell tip(GO:0051286) |
| 0.1 | 0.6 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 0.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 0.4 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
| 0.1 | 1.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 6.5 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.1 | 0.5 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.1 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.1 | 1.2 | GO:0000800 | lateral element(GO:0000800) |
| 0.1 | 11.6 | GO:0000922 | spindle pole(GO:0000922) |
| 0.1 | 0.7 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.1 | 2.1 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.1 | 0.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.1 | 0.7 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
| 0.1 | 5.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.1 | 1.2 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 1.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 2.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.1 | 2.6 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.1 | 1.8 | GO:0031094 | platelet dense tubular network(GO:0031094) |
| 0.1 | 0.3 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.1 | 0.7 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.1 | 1.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 0.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.1 | 0.4 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 0.5 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 0.9 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.1 | 0.5 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 0.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 0.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 0.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 0.5 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.1 | 1.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 1.9 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.1 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 0.6 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.1 | 1.9 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.1 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.1 | 0.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.1 | 0.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.1 | 1.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 0.2 | GO:0043257 | laminin-8 complex(GO:0043257) |
| 0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.0 | 0.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.0 | 0.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.0 | 3.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.0 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
| 0.0 | 2.2 | GO:0097546 | ciliary base(GO:0097546) |
| 0.0 | 1.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 3.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.0 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.0 | 0.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.0 | 1.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 0.5 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.6 | GO:0070938 | contractile ring(GO:0070938) |
| 0.0 | 0.5 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
| 0.0 | 1.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.8 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.0 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.0 | 1.8 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
| 0.0 | 0.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.0 | 7.6 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 0.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.0 | 0.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.0 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.0 | 1.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 0.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 0.1 | GO:0036457 | keratohyalin granule(GO:0036457) |
| 0.0 | 1.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.0 | 1.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.0 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 0.5 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 0.9 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.0 | 0.2 | GO:0044292 | dendrite terminus(GO:0044292) dendritic growth cone(GO:0044294) |
| 0.0 | 6.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.0 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.0 | 3.4 | GO:0005814 | centriole(GO:0005814) |
| 0.0 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
| 0.0 | 1.3 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 1.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.0 | 2.8 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
| 0.0 | 0.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.0 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.0 | 2.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.0 | 0.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 0.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.0 | 0.2 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.0 | 0.9 | GO:0043218 | compact myelin(GO:0043218) |
| 0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.0 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.0 | 0.1 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.0 | 0.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.0 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.0 | 0.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.0 | 0.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.0 | 0.9 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.0 | 0.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.0 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 0.6 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 1.7 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.0 | 2.0 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
| 0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.0 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 5.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 0.4 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.0 | 3.6 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.0 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.0 | 1.9 | GO:0005819 | spindle(GO:0005819) |
| 0.0 | 0.1 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.0 | 0.9 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
| 0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 0.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.9 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 2.5 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 0.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.0 | 0.1 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.0 | 0.8 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 1.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.0 | 0.0 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.0 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 0.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.0 | 0.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
| 0.0 | 0.4 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 0.1 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.0 | 0.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.0 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.0 | 0.4 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.0 | 0.5 | GO:0031672 | A band(GO:0031672) |
| 0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.0 | 13.8 | GO:0005730 | nucleolus(GO:0005730) |
| 0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.0 | 2.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 0.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) plasma membrane respiratory chain(GO:0070470) |
| 0.0 | 0.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
| 0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.0 | 0.3 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.0 | 3.4 | GO:0005813 | centrosome(GO:0005813) |
| 0.0 | 0.0 | GO:1990462 | omegasome(GO:1990462) |
| 0.0 | 0.1 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.0 | 0.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 1.6 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.0 | 0.2 | GO:0044754 | autolysosome(GO:0044754) |
| 0.0 | 0.5 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 0.1 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.0 | 4.0 | GO:0098791 | Golgi subcompartment(GO:0098791) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 3.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 1.1 | 3.4 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 1.0 | 3.0 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 0.8 | 2.3 | GO:0047017 | geranylgeranyl reductase activity(GO:0045550) prostaglandin-F synthase activity(GO:0047017) |
| 0.7 | 7.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.7 | 2.1 | GO:0004827 | glutamate-tRNA ligase activity(GO:0004818) proline-tRNA ligase activity(GO:0004827) |
| 0.6 | 1.9 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
| 0.6 | 1.9 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.6 | 1.9 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 0.6 | 1.7 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.6 | 1.7 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.5 | 2.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.5 | 1.6 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.5 | 2.4 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.5 | 1.9 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.5 | 1.4 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
| 0.5 | 1.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.5 | 2.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.4 | 5.5 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.4 | 1.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.4 | 1.2 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 0.4 | 1.1 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.4 | 3.8 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.4 | 2.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.4 | 1.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.4 | 1.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.4 | 2.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.4 | 3.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.4 | 1.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.3 | 1.4 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.3 | 1.0 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.3 | 2.0 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.3 | 1.0 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.3 | 1.3 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.3 | 2.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.3 | 1.8 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.3 | 1.5 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.3 | 1.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.3 | 0.9 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 0.3 | 0.9 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 0.3 | 0.8 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
| 0.3 | 0.8 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 0.3 | 1.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.3 | 2.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.3 | 0.8 | GO:0051908 | double-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0051908) |
| 0.3 | 1.0 | GO:0047860 | diiodophenylpyruvate reductase activity(GO:0047860) |
| 0.3 | 0.8 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 0.2 | 2.7 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.2 | 0.7 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.2 | 0.7 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
| 0.2 | 1.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
| 0.2 | 2.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.2 | 2.1 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.2 | 0.7 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.2 | 0.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.2 | 0.9 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.2 | 0.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.2 | 0.7 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.2 | 0.9 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) leukemia inhibitory factor receptor activity(GO:0004923) interleukin-6 binding(GO:0019981) |
| 0.2 | 1.9 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.2 | 1.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.2 | 1.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.2 | 3.0 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.2 | 1.5 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.2 | 1.9 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.2 | 1.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.2 | 0.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.2 | 0.6 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.2 | 0.6 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.2 | 1.0 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.2 | 1.6 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.2 | 2.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.2 | 1.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.2 | 0.4 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
| 0.2 | 1.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.2 | 1.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.2 | 0.6 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.2 | 7.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.2 | 1.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.2 | 1.3 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.2 | 0.5 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
| 0.2 | 1.3 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.2 | 1.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.2 | 1.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.2 | 0.5 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.2 | 1.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.2 | 0.7 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.2 | 0.7 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.2 | 1.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.2 | 2.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.2 | 1.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.2 | 0.8 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.2 | 0.5 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.2 | 3.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.2 | 0.3 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.2 | 0.5 | GO:0030626 | U12 snRNA binding(GO:0030626) |
| 0.2 | 0.7 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.2 | 0.5 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
| 0.2 | 0.7 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.2 | 0.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.2 | 2.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 0.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.2 | 1.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.2 | 1.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.2 | 0.9 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.2 | 0.2 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.2 | 9.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.2 | 4.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.2 | 4.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.2 | 2.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.2 | 1.2 | GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
| 0.1 | 1.0 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.1 | 1.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 1.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 6.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 1.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.1 | 1.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.1 | 4.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 0.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.1 | 0.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.1 | 1.0 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.1 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 0.6 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.1 | 0.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.1 | 1.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 0.8 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.1 | 0.4 | GO:0097689 | iron channel activity(GO:0097689) |
| 0.1 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 0.9 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.1 | 0.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.1 | 0.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.1 | 0.8 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.1 | 0.8 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.1 | 4.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 0.5 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.1 | 0.5 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.1 | 0.2 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
| 0.1 | 0.6 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.1 | 1.0 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.1 | 2.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 1.9 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.1 | 3.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 0.7 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.1 | 0.3 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
| 0.1 | 0.5 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.1 | 0.5 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.1 | 1.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 1.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 0.3 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.1 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.1 | 2.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 0.6 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.1 | 0.3 | GO:0015068 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.1 | 0.3 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 0.1 | 0.8 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.1 | 1.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 7.8 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.1 | 2.8 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.1 | 0.3 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.1 | 0.3 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.1 | 0.4 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.1 | 0.5 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 0.3 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.1 | 0.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.1 | 0.6 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.1 | 2.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.1 | 0.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.1 | 0.3 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
| 0.1 | 6.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.1 | 1.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 0.3 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.1 | 2.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 1.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.1 | 0.5 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.1 | 0.6 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.1 | 0.4 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.1 | 0.4 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.1 | 0.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 1.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 0.4 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.1 | 2.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 0.4 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
| 0.1 | 0.3 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
| 0.1 | 0.8 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.1 | 1.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.1 | 0.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.1 | 0.3 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.1 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.1 | 1.7 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 0.8 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.1 | 0.5 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.1 | 1.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 0.8 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.1 | 2.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.1 | 0.8 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 0.4 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.1 | 0.2 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.1 | 0.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.1 | 0.3 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.1 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 0.6 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.1 | 0.9 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.1 | 2.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 2.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 1.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.1 | 0.2 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
| 0.1 | 0.4 | GO:0032356 | oxidized DNA binding(GO:0032356) |
| 0.1 | 0.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.1 | 1.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.1 | 1.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 1.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 0.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.1 | 1.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 0.4 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.1 | 0.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.1 | 0.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 0.5 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.1 | 0.1 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
| 0.1 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.1 | 0.6 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.1 | 0.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.1 | 7.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.1 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 1.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.1 | 0.2 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.1 | 1.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.1 | 1.0 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.1 | 0.1 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 0.1 | 1.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 0.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 0.6 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 0.3 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.1 | 0.6 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.1 | 0.2 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.1 | 0.6 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 0.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 0.3 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.1 | 1.3 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.1 | 0.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 0.1 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.1 | 0.4 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.1 | 1.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 0.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 0.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.1 | 1.0 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.1 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.1 | 3.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 2.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 0.6 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.1 | 0.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 0.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 0.7 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 3.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.1 | 1.2 | GO:0016895 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
| 0.1 | 2.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 0.6 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 0.1 | 0.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.1 | 11.2 | GO:0004386 | helicase activity(GO:0004386) |
| 0.1 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.1 | 1.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.1 | 0.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.1 | 0.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) Toll-like receptor 2 binding(GO:0035663) |
| 0.1 | 1.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 4.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.1 | 0.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.1 | 0.1 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
| 0.1 | 1.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 2.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 0.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.1 | 2.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.1 | 1.2 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
| 0.1 | 0.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 0.3 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.1 | 0.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 1.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.1 | 0.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.1 | 1.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.1 | 0.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.1 | 0.4 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.1 | 0.2 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.1 | 1.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.1 | 1.2 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.1 | 0.4 | GO:0042835 | BRE binding(GO:0042835) |
| 0.1 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.1 | 0.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.1 | 0.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 1.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.0 | 0.2 | GO:0097617 | annealing activity(GO:0097617) |
| 0.0 | 0.1 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
| 0.0 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.0 | 0.4 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.0 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.0 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.0 | 0.2 | GO:1901474 | thiamine transmembrane transporter activity(GO:0015234) azole transmembrane transporter activity(GO:1901474) |
| 0.0 | 0.1 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.0 | 0.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.0 | 0.1 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.0 | 0.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.0 | 2.0 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 0.0 | 1.2 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.1 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
| 0.0 | 0.5 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.0 | 0.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.0 | 0.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.0 | 0.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.0 | 0.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.0 | 1.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.0 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.0 | 1.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 0.2 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.0 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.0 | 1.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.0 | 0.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.0 | 0.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
| 0.0 | 1.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.0 | 0.4 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.0 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.0 | 1.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.0 | 0.3 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.0 | 1.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.0 | 1.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 1.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.0 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.0 | 0.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 0.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.0 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.0 | 1.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 0.1 | GO:0030395 | lactose binding(GO:0030395) |
| 0.0 | 1.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.0 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.0 | 0.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 1.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 0.7 | GO:0005522 | profilin binding(GO:0005522) |
| 0.0 | 0.2 | GO:0004096 | catalase activity(GO:0004096) |
| 0.0 | 0.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.0 | 0.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.0 | 4.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.0 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
| 0.0 | 1.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.0 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.0 | 2.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.0 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.0 | 1.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 0.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.0 | 7.4 | GO:0042393 | histone binding(GO:0042393) |
| 0.0 | 0.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 0.0 | 1.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.0 | 0.1 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
| 0.0 | 1.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.0 | 0.2 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.0 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
| 0.0 | 1.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 1.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.0 | 0.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.0 | 2.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.0 | 0.2 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.0 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.0 | 2.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.0 | 0.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.0 | 0.1 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.0 | 1.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.0 | 0.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.0 | 1.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.0 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.0 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
| 0.0 | 0.4 | GO:0016849 | adenylate cyclase activity(GO:0004016) guanylate cyclase activity(GO:0004383) phosphorus-oxygen lyase activity(GO:0016849) |
| 0.0 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.0 | 1.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 0.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.0 | 0.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 0.6 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.0 | 0.4 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.0 | 6.4 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.0 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.0 | 0.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.0 | 1.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.0 | 0.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.0 | 1.5 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.0 | 1.7 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.0 | 0.1 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.0 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.0 | 0.1 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 0.0 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.0 | 0.9 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 5.6 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.0 | 0.1 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.0 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
| 0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.0 | 0.0 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 0.0 | 0.1 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.0 | 0.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.0 | 0.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.0 | 0.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.0 | 0.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.0 | 1.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.0 | 0.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.0 | 0.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.0 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.0 | 0.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.0 | 0.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 0.0 | 2.5 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.0 | 9.4 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
| 0.0 | 0.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.0 | 0.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.0 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.0 | 3.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 3.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.0 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.0 | 2.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 5.3 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 0.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 0.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
| 0.0 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.0 | 0.0 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.0 | 1.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.0 | 0.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.0 | 0.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.0 | 0.3 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
| 0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.0 | 0.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.0 | 0.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.0 | 0.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.0 | 0.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.0 | 0.3 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
| 0.0 | 0.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 0.1 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 0.0 | 0.8 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.0 | 0.9 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.0 | 0.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.0 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.0 | 0.5 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.7 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.0 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.0 | 0.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.0 | 0.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.0 | 0.5 | GO:0060590 | ATPase regulator activity(GO:0060590) |
| 0.0 | 0.1 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.0 | 0.3 | GO:0030276 | clathrin binding(GO:0030276) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 23.0 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.2 | 3.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.2 | 4.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 12.1 | PID ATR PATHWAY | ATR signaling pathway |
| 0.1 | 5.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 0.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.1 | 4.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 4.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.1 | 2.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.1 | 8.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.1 | 3.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 1.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 8.8 | PID E2F PATHWAY | E2F transcription factor network |
| 0.1 | 3.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 5.6 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
| 0.1 | 3.2 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.0 | 0.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.0 | 1.4 | PID ATM PATHWAY | ATM pathway |
| 0.0 | 0.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.0 | 7.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.0 | 3.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 1.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 2.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.0 | 1.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.0 | 2.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.0 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 4.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 1.2 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 1.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.0 | 1.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.0 | 2.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 0.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.0 | 2.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 1.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.0 | 1.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 1.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.0 | 0.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 1.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 1.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 1.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 0.5 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.0 | 1.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 0.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.0 | 2.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 0.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 0.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 1.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.0 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 0.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.0 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 1.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.0 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.0 | 0.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 0.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 0.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.0 | 1.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 0.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.0 | 1.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 0.8 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 0.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 1.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.4 | 19.2 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.3 | 5.0 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 0.3 | 10.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.2 | 1.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.2 | 2.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.2 | 1.8 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.2 | 10.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.2 | 11.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.2 | 5.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.2 | 23.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.2 | 5.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 2.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.1 | 2.6 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.1 | 3.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.1 | 0.5 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.1 | 8.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 6.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.1 | 4.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.1 | 4.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.1 | 0.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 1.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 3.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 4.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 5.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 0.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.1 | 8.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.1 | 3.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.1 | 1.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.1 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
| 0.1 | 2.8 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 0.1 | 1.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.1 | 8.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 3.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 1.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 1.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.1 | 1.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.1 | 1.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.1 | 2.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 1.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.1 | 2.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.1 | 3.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 3.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 1.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.1 | 1.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.1 | 1.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.1 | 0.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.1 | 0.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 0.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.1 | 2.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.1 | 0.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.1 | 0.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.1 | 0.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 1.8 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.1 | 2.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
| 0.1 | 0.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 1.1 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
| 0.1 | 1.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.1 | 1.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.1 | 0.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 1.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 2.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.1 | 1.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.1 | 2.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.1 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.1 | 0.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.1 | 1.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 0.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 2.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.1 | 1.5 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
| 0.0 | 1.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.0 | 1.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.0 | 1.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.0 | 0.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 1.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.0 | 1.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.0 | 1.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.0 | 0.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.0 | 2.9 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
| 0.0 | 1.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.0 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.0 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.0 | 3.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 0.7 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.0 | 2.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 0.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 4.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.0 | 0.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.0 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.0 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.0 | 2.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.0 | 0.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.0 | 0.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.0 | 2.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 9.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 0.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.0 | 1.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 1.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.0 | 0.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 0.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.0 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.0 | 1.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.0 | 0.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.0 | 0.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.0 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 0.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 0.6 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.0 | 1.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.0 | 0.3 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
| 0.0 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.0 | 1.8 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 0.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 0.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.0 | 0.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.0 | 0.5 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.0 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.0 | 1.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.0 | 1.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 0.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 0.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |